CMV Seropositivity Tied to Cortical Surface Area in Schizophrenia
Higher circulating CMV IgG antibody concentrations linked to smaller total cortical surface area in adults with schizophrenia
Veterans Report Low Rates of Adverse Events With mRNA Vaccines
Rates slightly higher at 42 days for those receiving Pfizer versus Moderna
Atogepant Prevents Migraine in Adults
Compared with placebo, increase in responder rates seen at all atogepant dose levels
Cost of Brand-Name Antiseizure Meds Increased Since 2010
Brand-name ASMs accounted for 79 percent of costs in 2018, despite representing only 14 percent of pill days
Early Identification Cuts Costs for Spinal Muscular Atrophy
Among treated patients, costs were lower for those identified by newborn screening versus presentation of symptoms
Herpes Zoster Not Linked to Increased Dementia Risk
Small reduction in risk for dementia seen after the first year for people with zoster versus general population comparators
Medicare Spending Spikes for Dementia Diagnoses in Seniors
Medicare spending higher for adults with a formal clinical diagnosis of dementia versus a positive screening for cognitive impairment
2016 to 2020 Saw Increase in Medical Cannabis Licensure
Percent of patients with conditions that had substantial or conclusive evidence of therapeutic value decreased from 2016 to 2020
Hospital Interns Spend Only 13.4 Percent of Time in Patient Rooms
Real-time locating systems may be used to improve the training experience, authors say
New ALS Drug Approved in Canada While Still Under FDA Review
Last month, 38 U.S. doctors who treat ALS patients sent a letter urging the FDA to approve the drug
